WHO ICTRP trial
Ultrasound-assisted treatment of inoperable pancreatic cancer. ”Behandling av…
EUCTR2010-024289-24-NO · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2010-024289-24-NO |
|---|---|
| Public title | Ultrasound-assisted treatment of inoperable pancreatic cancer. ”Behandling av inoperabel kreft i bukspyttkjertelen ved å kombinere kontrast ultralyd og gemcitabin under sonoporering” |
| Scientific title | TREATMENT OF PANCREATIC ADENOCARCINOMA BY COMBINING CONTRAST AGENT AND GEMCITABINE UNDER SONICATION - CEUS treatment |
| Primary sponsor | Helse Bergen HF, Haukeland Unversity Hospital |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Norway |
| Conditions | Patients with inoperable pancreatic cancer. Histologically verified, locally advanced (nonresectable Stage II/III) or metastatic (Stage IV) adenocarcinoma of the pancreas. The patients must be ambulatory with an ECOG performance status 0-2… |
| Interventions | Trade Name: Gemzar Product Name: Gemzar Pharmaceutical Form: Powder and solvent for concentrate for solution for infusion Trade Name: SonoVue Product Name: SonoVue Pharmaceutical Form: Powder and solution for solution for injection |
| Registration date | Sep 19, 2011 |
| Target size | 10 |
| Secondary IDs | 2010-024289-24 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: